WallStSmart

Strata Critical Medical, Inc. (SRTA)vsUniversal Health Services Inc (UHS)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Universal Health Services Inc generates 25757% more annual revenue ($17.36B vs $67.16M). UHS leads profitability with a 8.6% profit margin vs -55.0%. UHS earns a higher WallStSmart Score of 76/100 (B+).

SRTA

Hold

38

out of 100

Grade: F

Growth: 5.3Profit: 2.0Value: 5.0Quality: 5.0

UHS

Strong Buy

76

out of 100

Grade: B+

Growth: 7.3Profit: 7.0Value: 10.0Quality: 7.5
Piotroski: 6/9Altman Z: 2.97
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for SRTA.

UHSUndervalued (+78.6%)

Margin of Safety

+78.6%

Fair Value

$1081.08

Current Price

$186.72

$894.36 discount

UndervaluedFair: $1081.08Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

SRTA1 strengths · Avg: 10.0/10
Price/BookValuation
1.0x10/10

Reasonable price relative to book value

UHS4 strengths · Avg: 8.8/10
P/E RatioValuation
8.1x10/10

Attractively priced relative to earnings

Return on EquityProfitability
21.3%9/10

Every $100 of equity generates 21 in profit

Price/BookValuation
1.6x8/10

Reasonable price relative to book value

EPS GrowthGrowth
42.7%8/10

Earnings expanding 42.7% YoY

Areas to Watch

SRTA4 concerns · Avg: 3.3/10
Revenue GrowthGrowth
2.1%4/10

2.1% revenue growth

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$362.75M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-24.5%2/10

ROE of -24.5% — below average capital efficiency

UHS0 concerns · Avg: 0/10

No major concerns identified

Comparative Analysis Report

WallStSmart Research

Bull Case : SRTA

The strongest argument for SRTA centers on Price/Book.

Bull Case : UHS

The strongest argument for UHS centers on P/E Ratio, Return on Equity, Price/Book. PEG of 1.29 suggests the stock is reasonably priced for its growth.

Bear Case : SRTA

The primary concerns for SRTA are Revenue Growth, EPS Growth, Market Cap.

Bear Case : UHS

No major red flags identified for UHS, but monitor valuation.

Key Dynamics to Monitor

SRTA profiles as a turnaround stock while UHS is a value play — different risk/reward profiles.

UHS carries more volatility with a beta of 1.26 — expect wider price swings.

UHS is growing revenue faster at 9.1% — sustainability is the question.

UHS generates stronger free cash flow (293M), providing more financial flexibility.

Bottom Line

UHS scores higher overall (76/100 vs 38/100). Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Strata Critical Medical, Inc.

HEALTHCARE · MEDICAL CARE FACILITIES · USA

Strata Critical Medical, Inc. provides time critical logistics solutions and specialized medical services to healthcare providers across the United States. The company is headquartered in New York, New York.

Universal Health Services Inc

HEALTHCARE · MEDICAL CARE FACILITIES · USA

UnitedHealth Group Incorporated is an American for-profit multinational managed healthcare and insurance company based in Minnetonka, Minnesota. It offers health care products and insurance services.

Visit Website →

Want to dig deeper into these stocks?